Prifinium Bromide | CAS#4630-95-9 | antispasmodic agent

MedKoo Cat#: 563721 | Name: Prifinium Bromide

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Prifinium Bromide is an antispasmodic agent, inducing an appropriate smooth gastroenteric muscle relaxation.

Chemical Structure

Prifinium Bromide

CAS#4630-95-9 (Bromide)

Theoretical Analysis

MedKoo Cat#: 563721

Name: Prifinium Bromide

CAS#: 4630-95-9 (Bromide)

Chemical Formula: C22H28BrN

Exact Mass: 385.1405

Molecular Weight: 386.37

Elemental Analysis: C, 68.39; H, 7.30; Br, 20.68; N, 3.63

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

4630-95-9 (Bromide) 10236-81-4 (free base)

Synonym

Prifinium Bromide; Prifinium Br;

IUPAC/Chemical Name

3-Benzhydrylidene-1,1-diethyl-2-methylpyrrolidin-1-ium bromide

InChi Key

UCGJZJXOPSNTGZ-UHFFFAOYSA-M

InChi Code

InChI=1S/C22H28N.BrH/c1-4-23(5-2)17-16-21(18(23)3)22(19-12-8-6-9-13-19)20-14-10-7-11-15-20;/h6-15,18H,4-5,16-17H2,1-3H3;1H/q+1;/p-1

SMILES Code

CC1[N+](CC)(CC)CC/C1=C(C2=CC=CC=C2)\C3=CC=CC=C3.[Br-]

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 386.37 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Ishikawa Y, Usui T, Yamashita M, Kanemori Y, Baba T. Surfing and Swimming of Ejaculated Sperm in the Mouse Oviduct. Biol Reprod. 2016 Apr;94(4):89. doi: 10.1095/biolreprod.115.135418. Epub 2016 Mar 9. PubMed PMID: 26962118. 2: Tsumagari S, Ishinazaka T, Kamata H, Ohba S, Tanaka S, Ishii M, Memon MA. Induction of canine pyometra by inoculation of Escherichia coli into the uterus and its relationship to reproductive features. Anim Reprod Sci. 2005 Jul;87(3-4):301-8. Epub 2004 Dec 29. PubMed PMID: 15911179. 3: Moriyoshi M, Maruyama Y, Iseki H, Nakada K, Nakao T. Induction of parturition in bitches with minimal side effects by two injections of a low dose of fenprostalene, a prostaglandin F2alpha analogue, and pretreatment with prifinium bromide. J Vet Med Sci. 1999 Jul;61(7):781-6. PubMed PMID: 10458101. 4: Fieni F, Dumon C, Tainturier D, Bruyas JF. Clinical protocol for pregnancy termination in bitches using prostaglandin F2 alpha. J Reprod Fertil Suppl. 1997;51:245-50. PubMed PMID: 9404292. 5: Ishikawa S. [Ophthalmopathy due to environmental toxic substances especially intoxication by organophosphorus pesticides]. Nippon Ganka Gakkai Zasshi. 1996 Jun;100(6):417-32. Japanese. PubMed PMID: 8712073. 6: Magalini M, Monica F. [Use of prifinium bromide in endoscopic premedication. A double-blind controlled study vs hyoscine N-butylbromide]. Minerva Gastroenterol Dietol. 1995 Jun;41(2):197-202. Italian. PubMed PMID: 7647144. 7: Guslandi M. [The clinical pharmacological profile of pinaverium bromide]. Minerva Med. 1994 Apr;85(4):179-85. Review. Italian. PubMed PMID: 8028745. 8: Ishikawa S, Miyata M, Aoki S, Hanai Y. Chronic intoxication of organophosphorus pesticide and its treatment. Folia Med Cracov. 1993;34(1-4):139-51. PubMed PMID: 7909789. 9: Amarenco G, Kerdraon J, Adba MA, Ido G, Lacroix P. [Value of the prifinium bromide test in hyperactive bladder]. Presse Med. 1992 Mar 7;21(9):438. French. PubMed PMID: 1348856. 10: Rugolo S, Russo S, Di Stefano F, Marino I, Baiamonte P, Garraffo S. [Effect of some drugs on physiological icterus in the newborn]. Minerva Ginecol. 1991 Dec;43(12):569-72. Italian. PubMed PMID: 1687895. 11: Terai T, Deguchi Y, Ohtsuka M, Kumada S. Effects of the anticholinergic drug prifinium bromide on urinary bladder contractions in rat in vivo and in guinea-pig in vitro. Arzneimittelforschung. 1991 Apr;41(4):417-20. PubMed PMID: 1677577. 12: Bettini V, Martino R, Norani M, Ton P, Legrenzi E. [Cholinomimetics effects of carnitine on isolated and denervated rat stomach preparations]. Farmaco Sci. 1986 Jul;41(7):530-8. Italian. PubMed PMID: 3743746. 13: Tamura O, Mitsui Y. The magician's forceps phenomenon in exotropia under general anaesthesia. Br J Ophthalmol. 1986 Jul;70(7):549-52. PubMed PMID: 2872915; PubMed Central PMCID: PMC1041065. 14: Bettini V, Catozzo C, Martino R, Mayellaro F, Munari L, Tegazzin V, Ton P. [Changes in acetylcholine contractions induced by carnitine in coronary vessels isolated "in vitro"]. Acta Vitaminol Enzymol. 1985;7(1-2):61-9. Italian. PubMed PMID: 2863965. 15: Sasaki T, Takekoshi T, Okada T. Results of prifinium bromide therapy in irritable bowel syndrome. Clin Ther. 1985;7(4):512-21. PubMed PMID: 2861900. 16: Sasaki D, Suzuki A, Yoshida Y, Okamoto K, Ohmi T, Takahashi S, Yoshida S, Fukushi K, Higuchi K. Treatment of irritable bowel syndrome with prifinium bromide. Clin Ther. 1985;7(2):190-8. PubMed PMID: 2859117. 17: Kobayashi K, Mitani E, Tatsumi S, Sasaki Y, Nakamura M, Yamada H. Studies on papillary function and effect of prifinium bromide and other antispasmodics on motility of the papillary region (sphincter of Oddi) in humans. Clin Ther. 1985;7(2):154-63. PubMed PMID: 2859116. 18: Sasaki D, Kido A, Yoshida Y. Effect of antispasmodic drugs on the colonic motility. Part II: Clinical study in man. Int J Clin Pharmacol Ther Toxicol. 1984 Jul;22(7):338-41. PubMed PMID: 6147312. 19: Sasaki D, Kido A, Yoshida Y. Effect of antispasmodic drugs on colonic motility. Part I: Laboratory study of the dog. Int J Clin Pharmacol Ther Toxicol. 1984 Jul;22(7):333-7. PubMed PMID: 6147311. 20: Subissi A, Brunori P, Bachi M. Effects of spasmolytics on K+-induced contraction of rat intestine in vivo. Eur J Pharmacol. 1983 Dec 23;96(3-4):295-301. PubMed PMID: 6144556.

View History

MMV028038

MedKoo CAT#: 558722

CAS#: NONE